Description
Product Description:
Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
Aromatase inhibitors as initial endocrine therapy in postmenopausal women.
Fulvestrant in women with disease progression after endocrine therapy.
Features:
Product Name: Palbonix
Generic name: palbociclib
Dosage form: capsule
Available pack sizes: 21`s pot
Effective dose: 125 mg
Registration: Export only
Reviews
There are no reviews yet.